CIK 0000899923
- Accelerated filer
MYRIAD GENETICS INC
Sign in to watch- Ticker
- MYGN
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 870494517
- Phone
- +1 801-584-3600
- Business address
- 322 NORTH 2200 WEST, SALT LAKE CITY, UT, 84116
- Former names
- MYRIAD GENETICS INC
- 4 Grant or award Chief People Officer acquired 19,520 shares (grant or award)
- 4 Grant or award Chief Operating Officer acquired 43,295 shares (grant or award)
- 4 Grant or award President, Mental Health acquired 22,616 shares (grant or award)
- 4 Grant or award President and CEO acquired 234,271 shares (grant or award)
- 5 Insider Annual Insider Trading Report
- 4 Insider Changes in Ownership
- 4 Grant or award Lambert Nicole acquired 10,000 shares (grant or award)
- 4 Grant or award Chief People Officer acquired 143 shares (grant or award)
- 3/A Insider 3/A
- 4 Grant or award Chief Legal Officer acquired 15,753 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Shares withheld for taxes President, Myriad Neuroscience gave up 8,340 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 12,398 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Scientific Officer gave up 10,811 shares (to pay taxes)
- 4 Shares withheld for taxes Lambert Nicole gave up 12,483 shares (to pay taxes)
- 4 Shares withheld for taxes Chief People Officer gave up 4,926 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Technology Officer gave up 1,729 shares (to pay taxes)
- 3/A Insider 3/A
- 4 Open-market sale Lambert Nicole sold 1,420 shares at $31.57 ($44,835)
- 4 Open-market sale Lambert Nicole sold 10,112 shares at $33.10 ($334,747)
Page 16 of 65 · 1,294 filings